Weigh Pros and Cons of SGLT2 Inhibitors for Kidney Protection
You'll see more interest in using SGLT2 inhibitors (Invokana, etc) for renal protection in patients with type 2 diabetes.
Earlier findings from CV studies suggest SGLT2 inhibitors may protect the kidneys...probably by lowering intraglomerular pressure.
Now there's evidence in patients with chronic kidney disease.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote